Catalyst
Slingshot members are tracking this event:
Array BioPharma Announces FDA Acceptance of Binimetinib NDA for Patients with Advanced NRAS-Mutant Melanoma
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ARRY |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 01, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Binimetinib, Phase 3 Nemo, Nras Melanoma And Mek Inhibitor
